What Happens in a Prostate Exam? What the Research Says

A prostate exam is a routine check that looks for signs of prostate cancer, an enlarged prostate, or other prostate conditions. It usually involves two parts: a blood test called a PSA test and a digital rectal exam, often called a DRE. The PSA test measures a protein made by the prostate, while the DRE lets a doctor physically feel the gland for hard lumps or abnormal texture. Both steps are quick, take only a few minutes, and are done in a doctor’s office with no special preparation needed.

Why Do You Need a Prostate Exam?

The main purpose of a prostate exam is screening. Screening means checking for a disease in people who have no symptoms. Prostate cancer often grows slowly and may not cause any symptoms for years. A prostate exam can find signs of cancer early, when treatment is more likely to work.

Doctors also use prostate exams to evaluate symptoms. If a man has trouble urinating, needs to urinate often, or has blood in his urine, a prostate exam can help find the cause. The prostate sits right below the bladder and wraps around the urethra, so when it grows, it can squeeze the tube that carries urine out of the body.

Not every man needs a prostate exam at the same age. The decision depends on risk factors like family history and race. Your doctor will discuss when to start screening and how often to repeat it based on your personal risk profile.

What Happens in a Prostate Exam: The PSA Blood Test

The PSA test is a simple blood draw. A technician takes blood from a vein in your arm, and the sample goes to a lab for analysis. PSA stands for prostate-specific antigen, a protein made by prostate cells. Small amounts of PSA normally enter the bloodstream, and higher levels can signal a problem.

A normal PSA level is generally considered to be below 4 nanograms per milliliter. Levels above that range raise concern, but they do not confirm cancer. Many things besides cancer can raise PSA, including an enlarged prostate, a urinary tract infection, recent ejaculation, or a long bike ride. Some men with prostate cancer have normal PSA levels, so the test is not perfect.

Doctors look at PSA trends over time, not just a single number. A rapid rise in PSA from one year to the next is more concerning than a slow, steady increase. Your age and prostate size also matter when interpreting the result.

What Happens in a Prostate Exam: The Digital Rectal Exam

The digital rectal exam is the part most men worry about, but it is brief and usually not painful. You will be asked to undress from the waist down and stand bending over an exam table, or lie on your side with your knees drawn toward your chest. The doctor wears a lubricated glove and gently inserts one finger into the rectum.

Because the prostate sits just in front of the rectum, the doctor can feel its back surface through the rectal wall. The exam takes about 10 to 15 seconds. The doctor checks the prostate for size, firmness, and any hard nodules or irregular areas that might suggest cancer.

A normal prostate feels smooth and rubbery, similar to the texture of the base of your thumb. An enlarged prostate feels larger than expected but still smooth. A hard lump or an irregular, stony texture is the finding that raises the most concern for cancer.

Some men feel a brief urge to urinate during the exam. Others feel mild discomfort that passes as soon as the finger is removed. Serious complications from a DRE are extremely rare. The exam does not cause cancer or spread it.

What Do the Results Mean?

Results from a prostate exam come in two forms. The PSA blood test gives a numerical value, and the DRE gives a physical description. Doctors combine both findings to decide whether more testing is needed.

If both the PSA and DRE are normal, your doctor will likely recommend repeating the screening at an interval based on your age and risk. For many men, that means every one to two years. If the PSA is mildly elevated but the DRE feels normal, your doctor may repeat the blood test in a few weeks or months before deciding on next steps.

If the DRE finds a suspicious lump or the PSA is significantly elevated, your doctor will usually recommend a prostate biopsy. A biopsy is the only way to confirm whether cancer is present. During a biopsy, a doctor uses ultrasound guidance to take small tissue samples from the prostate with thin needles. The samples go to a lab where a pathologist examines them under a microscope.

It is important to understand that most men with an elevated PSA do not have cancer. Research consistently shows that about three out of four men who have a biopsy after an abnormal screening result do not have prostate cancer. Many of those men have benign prostatic hyperplasia, or BPH, a non-cancerous enlargement of the prostate that becomes more common with age.

How Accurate Are Prostate Exams?

Prostate screening has real limits, and researchers have studied these limits carefully. The PSA test detects many cancers, but it also misses some and raises false alarms in others. The DRE can feel only the back of the prostate, so it misses cancers in other parts of the gland.

The evidence on whether prostate screening saves lives is mixed. Large clinical trials have reached different conclusions. One major European study found that PSA screening reduced prostate cancer deaths by about 20 percent over many years of follow-up. A large US study found no significant reduction in deaths from screening. Both studies agree that screening leads to overdiagnosis, meaning it finds some cancers that would never have caused symptoms or harm.

This is why medical organizations do not all agree on screening recommendations. Some recommend discussing screening with your doctor starting at age 50, or age 45 for men at higher risk. Others suggest a more cautious approach, emphasizing shared decision-making between the patient and doctor. The United States Preventive Services Task Force currently recommends that men aged 55 to 69 make an individual decision about PSA screening after discussing the benefits and harms with their clinician.

The key point is that a prostate exam is a screening tool, not a diagnosis. An abnormal result does not mean you have cancer. It means you need more information, usually through additional testing or a biopsy.

How to Prepare for a Prostate Exam

Preparation is simple. You do not need to fast, stop medications, or do anything special before a PSA blood test. However, certain activities can temporarily raise PSA levels, so it helps to avoid them for 48 hours before the blood draw.

These activities include ejaculation, vigorous exercise like cycling, and having a urinary tract infection. If you have a urinary tract infection, your doctor will likely postpone the PSA test until the infection clears. Let your doctor know about any recent illness, procedure, or vigorous activity before the blood draw.

For the DRE, no preparation is needed. You may want to empty your bladder before the exam for comfort. If you have hemorrhoids or anal fissures, tell your doctor. The exam can still be done, but your doctor will be extra gentle.

Some medications can affect PSA levels. Finasteride and dutasteride, drugs used to treat an enlarged prostate, typically lower PSA by about half. If you take these medications, your doctor will interpret your PSA result differently. Always tell your doctor about every medication and supplement you take.

What Does the Research Say About Prostate Exam Benefits?

Research shows that prostate screening finds cancers earlier than waiting for symptoms. Cancers found through screening tend to be smaller and more localized, meaning they have not spread beyond the prostate. This gives men more treatment options, including active surveillance, which means monitoring a low-risk cancer closely rather than treating it immediately.

Research also shows that screening has costs. The main harm is overdiagnosis. Some prostate cancers grow so slowly that they would never cause symptoms or shorten a man’s life. Finding these cancers leads to unnecessary anxiety, additional testing, and sometimes treatment with side effects like erectile dysfunction and urinary incontinence.

The balance between benefits and harms is different for every man. A 55-year-old with a family history of aggressive prostate cancer faces a different risk profile than a 70-year-old with other serious health conditions. This is why experts emphasize individualized decision-making rather than a one-size-fits-all screening schedule.

Recent research has focused on improving screening accuracy. MRI scans before biopsy can help identify suspicious areas more precisely. Newer blood tests and genetic markers are being studied to better distinguish aggressive cancers from harmless ones. These tools are not yet standard for everyone, but they represent the direction of prostate cancer screening.